ErbB2 Recombinant Rabbit mAb (SDT-069-10)

產(chǎn)品型號(hào)：S0B2078

更新時(shí)間：2025-10-09

廠(chǎng)商性質(zhì)：生產(chǎn)廠(chǎng)家

訪(fǎng)問(wèn)量：134

服務(wù)熱線(xiàn)

15855403091

立即咨詢(xún)

產(chǎn)品分類(lèi)

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

重組兔單抗能否成為下一代抗體技術(shù)的前沿者？

促紅細(xì)胞生成素：其生理機(jī)制與臨床應(yīng)用知多少？

外泌體介導(dǎo)的IFN-α抗HBV效應(yīng)傳遞機(jī)制研究

產(chǎn)品介紹

Receptor tyrosine-protein kinase erbB-2 is a protein that in humans is encoded by the ERBB2 gene. ERBB is abbreviated from erythroblastic oncogene B. The human protein is also frequently referred to as HER2 （human epidermal growth factor receptor 2） or CD340 （cluster of differentiation 340）. HER2 is a member of the human epidermal growth factor receptor （HER/EGFR/ERBB） family. But contrary to other member of the ERBB family, HER2 does not directly bind ligand. HER2 activation results from heterodimerization with another ERBB member or by homodimerization when HER2 concentration are high, for instance in cancer. Amplification or over-expression of this oncogene has been shown to play an important role in the development and progression of certain aggressive types of breast cancer. In recent years the protein has become an important biomarker and target of therapy for approximately 30% of breast cancer patients.

上一個(gè)：S0B2079CDX2 Recombinant Rabbit mAb (SDT-134-76)